AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07701668
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Mild Cognitive Impairment (MCI)
- Social Isolation
Eligibility Criteria
- Sex
- ALL
- Age
- 75 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- AI-based conversational intervention — BEHAVIORALAI-based one-on-one semi-structured conversation for cognitive stimulation
Study Details
This randomized controlled trial examines the mechanisms of conversational AI-based interventions for early dementia prevention in socially isolated older adults.
Key Dates
- First listed
- Jul 14, 2026
- Start date
- Oct 1, 2026
- Status verified
- Aug 2026
- Primary completion
- May 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: AI-CONECTParticipants will receive four 15- to 30-minute conversations per week with the AI agent and a weekly 10- to15-minute survey call with a human interviewer.
- No Intervention: ControlParticipants will receive a weekly 10- to 15-minute survey call with a human interviewer.
Primary Outcome Measure
Social Self-Efficacy [ Time Frame: From enrollment to the end of intervention at 8 weeks ]
Central Contacts
- Catherine Young617-724-2428
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02129 |
Find similar trials in Boston, MA
By research site
Related Studies
- Treating Insomnia in Mild Cognitive ImpairmentRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Mindfulness for Cognition in Early-stage Alzheimer's DiseaseRecruiting · VA Boston Healthcare System · Boston, Massachusetts
- Biomarker-based Trial of NPC-1 for Alzheimer's PathologyPHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's DiseaseRecruiting · Boston University Charles River Campus · Boston, Massachusetts